European Leukemia Trial Registry
Trial: ENESTop

More Details
Title Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib
Scientific Title A Phase II, Single Arm, Open Label Study of Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Short Title ENESTop
Trialgroup NN
Type of Trial multicentric, single-group, prospective, open-label
Disease Chronic myeloid leukemia(CML) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 01.12.2012
Leader Le Coutre, Dr. med., Phillipp
Shortprotocol Shortprotocol
created 05.08.2013 Johannes Kraus
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org